top of page
About Us
Building advanced manufacturing technology for life.
Spun out from Harvard in 2022, AcousticaBio is a venture-backed, NIH-funded preclinical biotechnology company focused on solving the greatest challenges in the delivery of novel therapeutics by using our proprietary fluid processing technology. With strong in-vitro and in-vivo safety and efficacy data, we've built collaborations with leading global biopharmaceutical companies.
TEAM
The future of life sciences requires innovative experts.
We're building a better future.
Professor Jennifer Lewis
SCIENTIFIC CO-FOUNDER
ADVISORS
Anjali Kumar, Ph.D.
BD & DRUG DEV. ADVISOR
Professor Mark Skylar-Scott
SCIENTIFIC ADVISOR
Marcello Damiani, MBA
STRATEGIC ADVISOR
bottom of page